Showing results (311-320 of 391) with videos related to

Sort By:
Pageof 40
The Journal of Pathology|January 24, 2025
SMARCB1-deficient malignant melanocytic uveal tumours: a new neural crest-derived tumour entity with SMARCB1-related germline predispositionJoanna Cyrta, Julien Masliah-Planchon, Owen Hoare, et al.
The American Journal of Surgical Pathology|June 14, 2013
Lobular neoplasia of the breast revisited with emphasis on the role of E-cadherin immunohistochemistryDavid J Dabbs, Stuart J Schnitt, Felipe C Geyer, et al.
Nature Communications|May 3, 2024
CD74 supports accumulation and function of regulatory T cells in tumorsElisa Bonnin, Maria Rodrigo Riestra, Federico Marziali, et al.
JCO Precision Oncology|September 11, 2020
Exploitation of Precision Medicine Trials Data: Examples of Long Responders From the SHIVA01 TrialClémence Basse, Claire Morel, Céline Callens, et al.
Ebiomedicine|July 26, 2022
Timing evolution of lobular breast cancer through phylogenetic analysisDanai Fimereli, David Venet, Mattia Rediti, et al.
International Journal of Molecular Sciences|February 23, 2020
Early Modulation of Circulating MicroRNAs Levels in HER2-Positive Breast Cancer Patients Treated with Trastuzumab-Based Neoadjuvant TherapySerena Di Cosimo, Valentina Appierto, Sara Pizzamiglio, et al.
NPJ Breast Cancer|March 21, 2024
Reporting on invasive lobular breast cancer in clinical trials: a systematic reviewKaren Van Baelen, Josephine Van Cauwenberge, Marion Maetens, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|August 6, 2016
Genetic events in the progression of adenoid cystic carcinoma of the breast to high-grade triple-negative breast cancerNicola Fusco, Felipe C Geyer, Maria R De Filippo, et al.
Nature Communications|July 14, 2023
Oxidative phosphorylation is a metabolic vulnerability of endocrine therapy and palbociclib resistant metastatic breast cancersRania El-Botty, Ludivine Morriset, Elodie Montaudon, et al.
Diagnostic and Interventional Imaging|June 1, 2026
Breast cryoablation for small, low-risk breast cancers: Current evidence, practical integration, and future directionsToulsie Ramtohul, Youlia Kirova, Corinne Balleyguier, et al.
Pageof 40